Skip to main content
. 2017 Oct 27;6(11):e006609. doi: 10.1161/JAHA.117.006609

Figure 4.

Figure 4

Subgroup analysis of the mortality rates among patients with metabolic syndrome (MetS) by number of MetS components, not including impaired fasting glucose (IFG), compared with the same number of components including IFG (1 of the components is IFG).